| scholarly article | Q13442814 |
| P2093 | author name string | Elinore F. McCance-Katz | |
| P2860 | cites work | Effect of cocaine use on buprenorphine pharmacokinetics in humans | Q43173623 |
| Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401. | Q43639001 | ||
| Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series | Q43813287 | ||
| Effect of opioid dependence pharmacotherapies on zidovudine disposition | Q43849352 | ||
| Pharmacokinetic Drug Interactions with Nevirapine | Q43854429 | ||
| Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome | Q44349294 | ||
| The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients | Q44540993 | ||
| Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine | Q44916978 | ||
| Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine | Q44924769 | ||
| Novel metabolites of buprenorphine detected in human liver microsomes and human urine | Q46871062 | ||
| Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine. | Q51577509 | ||
| Norcocaine and N-hydroxynorcocaine formation in human liver microsomes: role of cytochrome P-450 3A4. | Q51665059 | ||
| Cardiac and autonomic nervous system effects of L-alphacetylmethadol (LAAM). | Q53931680 | ||
| Modified Directly Observed Therapy (MDOT) for Injection Drug Users with HIV Disease | Q58118151 | ||
| Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes | Q71610108 | ||
| Interaction of methadone with didanosine and stavudine | Q74254757 | ||
| Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262) | Q77142037 | ||
| Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs | Q28249840 | ||
| Rifampin-Induced Methadone Withdrawal | Q28342068 | ||
| The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. | Q29399138 | ||
| Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies | Q29616299 | ||
| Hepatitis C: an update on the silent epidemic | Q33871639 | ||
| The effect of fluconazole on the clinical pharmacokinetics of methadone | Q34749261 | ||
| Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. | Q35738878 | ||
| Clinically relevant drug interactions with antiepileptic drugs | Q35827491 | ||
| Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review | Q35906594 | ||
| Office-based buprenorphine treatment for opioid-dependent patients | Q36069743 | ||
| Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity | Q36637864 | ||
| A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals | Q37013041 | ||
| Lack of clinically significant drug interactions between nevirapine and buprenorphine | Q37045349 | ||
| Injection drug use and human immunodeficiency virus infection | Q40405946 | ||
| Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy | Q40614437 | ||
| Effect of cocaine use on methadone pharmacokinetics in humans | Q43173619 | ||
| ??? | Q26995469 | ||
| P433 | issue | 21-22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pregnant person | Q104720811 |
| P304 | page(s) | 953-958 | |
| P577 | publication date | 2010-10-19 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women | |
| Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: Implications for pregnant women | |||
| P478 | volume | 88 |
| Q90572975 | A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment |
| Q38115201 | Buprenorphine use in pregnant opioid users: a critical review |
| Q42638163 | Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy |
| Q39026878 | Main mental disorders in crack-cocaine users treated at Psychosocial Care Centers for Alcohol and Drugs in the city of Recife, Brazil |
| Q34952233 | New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone |
| Q38090461 | Pain treatment in patients infected with human immunodeficiency virus in later stages: pharmacological aspects |
Search more.